{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:57Z","timestamp":1786650057435,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.4103\/0028-3886.103177","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T09:32:12Z","timestamp":1351935132000},"page":"459-460","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Optic neuritis"],"prefix":"10.4103","volume":"60","author":[{"given":"Rohit","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20240802","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitisoptica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"R2-1-20240802","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol"},{"key":"R4-1-20240802","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaapos.2011.05.020","article-title":"Pediatric optic neuritis and risk of multiple sclerosis: Meta-analysis of observational studies","volume":"15","author":"Waldman","year":"2011","journal-title":"J AAPOS"},{"key":"R5-1-20240802","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0b013e31816f27fe","article-title":"Acute inflammatory demyelinating optic neuritis evidence-based visual and neurological considerations","volume":"14","author":"AbouZeid","year":"2008","journal-title":"Neurologist"},{"key":"R6-1-20240802","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: A systematic review and meta-analysis","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurol"},{"key":"R7-1-20240802","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0028-3886.103186","article-title":"Optic neuritis: Experience from a south Indian demyelinating disease registry","volume":"60","author":"Pandit","year":"2012","journal-title":"Neurol India"},{"key":"R8-1-20240802","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1212\/01.wnl.0000313843.78606.cd","article-title":"To test or not to test: NMO-IgG and optic neuritis","volume":"70","author":"Giovannoni","year":"2008","journal-title":"Neurology"},{"key":"R9-1-20240802","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomized study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"R10-1-20240802","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferonbeta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J Med"},{"key":"R11-1-20240802","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"R12-1-20240802","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"for the PreCISe study group. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): A randomized, double-blind, placebo-controlled trial","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"},{"key":"R13-1-20240802","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(11)70262-9","article-title":"Comparison of two dosing frequencies of subcutaneousinterferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): A phase 3 randomized controlled trial","volume":"11","author":"Comi","year":"2012","journal-title":"Lancet Neurol"},{"key":"R14-1-20240802","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.0b013e31818f3d6f","article-title":"Early treatment of multiple sclerosis to prevent neurologic damage","volume":"71","author":"Coyle","year":"2008","journal-title":"Neurology"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02223311-201260050-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:01:33Z","timestamp":1786647693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02223311-201260050-00001"}},"subtitle":["A blurry issue"],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.103177","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}